Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 553 of 6351
-
Can a Three-Drug inhaler outperform the standard Two-Drug treatment for asthma?
Disease control CompletedThe goal of this clinical trial is to evaluate whether two different doses of an investigational drug (CP006 Inhalation Powder, a triple combination of budesonide, formoterol, and umeclidinium) improve lung function in adults with asthma compared to an active comparator (budesoni…
Phase 2 • Sponsor: Shanghai Xin Huanghe Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Brain training with real-time scans shows promise for depression relief
Symptom relief Recruiting nowThis study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New drug targets Life-Threatening immune storm in rheumatic patients
Disease control Recruiting nowA study designed to evaluate the efficacy, safety, immunogenicity, PK, and PD characteristics of Plonmarlimab in patients with relapsed/refractory rheumatic and immunologic disease-associated MAS, and to explore biomarkers related to the efficacy of Plonmarlimab.
Phase 3 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail targets rare childhood cancer
Disease control Recruiting nowPatients participating in this study have DSRCT that has spread locally or to other parts of the body and can no longer be surgically removed without causing significant harm. Treatment will continue until the tumor progresses further, severe side effects occur, or either patien…
Phase 2 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New HPV vaccine shows promise in protecting young girls and women
Vaccine OngoingThis vaccine was jointly developed by Chengdu Institute of Biological Products Co., Ltd. and National Vaccine and Serum Institute, China, is co-sponsoring this clinical trial. This trial plans to enroll 1,800 female subjects aged 9-35 years, 450 in each of the 18-25 years old 3-…
Phase 3 • Sponsor: National Vaccine and Serum Institute, China • Aim: Vaccine
Last updated Jun 27, 2026 08:13 UTC
-
Can a 4-Month TB regimen work as well as 6 months?
Disease control Recruiting nowThis study is a randomized controlled trial among asymptomatic tuberculosis individuals aiming to assess whether the standard treatment duration can be shortened to 17 weeks without increasing the types or doses of anti-tuberculosis medications or 13 weeks with the high-dose rifa…
Phase 4 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Experimental ‘In vivo’ CAR-T therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, single-center, dose-escalation Phase I platform study designed to evaluate the safety, tolerability, preliminary efficacy, pharmacokinetics, and pharmacodynamics of an in vivo CAR-T therapy (V001 Injection, targeting BCMA, GPRC5D, DLL3,FcRH5, etc…
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Precision radiation may boost transplant success in tough leukemia cases
Disease control Recruiting nowThis is an open-label, single-center, non-randomized phase I/II pilot study evaluating proton-based Total Marrow Irradiation (TMI) as part of the conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult patients with high-risk or relap…
Phase 1/2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo aims to save esophagus in advanced cancer patients
Disease control Recruiting nowThis study is a prospective, exploratory clinical study aimed at evaluating the feasibility and safety of camrelizumab combined with synchronous chemoradiotherapy as an organ-preserving strategy for locally advanced resectable esophageal squamous cell carcinoma. The study target…
Phase 2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a Two-Drug combo beat single painkiller after stomach surgery?
Symptom relief OngoingThis prospective, randomized, phase 4 clinical trial aims to evaluate the efficacy and safety of intravenous Maxigesic, a fixed-dose combination of acetaminophen and ibuprofen, for postoperative pain control in patients undergoing laparoscopic or robotic gastrectomy for gastric c…
Phase 2 • Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New method aims to help premature babies breathe easier without a breathing tube
Disease control By invitation onlyThe purpose of this research is to learn new information that may help other infants that have respiratory distress syndrome and need breathing support after birth. The goal of this research is to see if continuous positive airway pressure (CPAP) alone or CPAP with surfactant adm…
Sponsor: Sharp HealthCare • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a single dose predict autism treatment success?
Symptom relief Recruiting nowstudy with arbaclofen (4 weeks of titration and then 6 weeks of active/stable treatment). The effects of arbaclofen on target EEG and ERG metrics will be associated with the clinical response in measures of social and general function, adaptive behaviour, social anxiety, sensory …
Phase 3 • Sponsor: Hospital General Universitario Gregorio Marañon • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to stop youth mental health crises before they start
Prevention Recruiting nowThis randomized controlled trial aims to evaluate the effectiveness of participation in five different STIME (Strengthened Cross-Sectoral Initiative for Children and Young People's Mental Health) interventions: 'Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Sel…
Sponsor: Center for Clinical Research and Prevention • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Sound waves target kidney fat to lower stubborn blood pressure
Disease control Not yet recruitingThe goal of this clinical trial is to investigate if focused power ultrasound (FPU) targeted perirenal adipose tissue modification therapy would be effective and safe in treating resistant hypertension. The primary outcome of the study is the difference in the reduction of 24h me…
Phase 3 • Sponsor: Yan Li • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New shot before angioplasty may shield heart attack patients
Disease control Not yet recruitingThe goal of this clinical trial is to learn if drug tafolecimab works to treat participants with acute myocardial infarction (AMI) scheduled for primary percutaneous coronary intervention (PCI). It will also learn about the safety of drug tafolecimab. The main questions it aims t…
Phase 4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug cocktail targets Hard-to-Treat bladder cancer
Disease control Recruiting nowThis is a multicenter, open-label, Phase II clinical trial to evaluate the efficacy and safety of Trastuzumab Rezetecan (SHR-A1811) or in combination with Adebrelimab (SHR-1316) for HER2-expressing locally advanced or metastatic urothelial carcinoma (la/mUC).
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to shrink tough stomach cancers
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the addition of ivonescimab to standard chemotherapy in patients with advanced or metastatic gastric and gastroesophageal adenocarcinoma. The main question it aims to answer is : Does the addition of ivonescimab increase the response…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could less radiation be better for some head and neck cancers?
Disease control Recruiting nowThis study aims to explore the efficacy and adverse events of reduced-dose radiotherapy (40.2Gy) versus conventional-dose radiotherapy (49.2Gy) to low-risk target volume for chemosensitive intermediate-stage nasopharyngeal carcinoma patients.
Phase 3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a targeted drug be safely used in children with rare tumors?
Disease control Recruiting nowThis study will collect safety information during routine medical care for children and adolescents in Japan who have been diagnosed with NTRK fusion-positive advanced or recurrent solid tumors who start treatment with repotrectinib. The study will describe how often side effects…
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New novavax JN.1 vaccine trial aims to protect adults 50-64 from COVID
Vaccine OngoingThis is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19 vaccine. Approximately 6,500 healthy adults aged 50 to under 65 will be randomized to receive either the vaccine or a placebo, with follow-up for …
Phase 4 • Sponsor: Novavax • Aim: Vaccine
Last updated Jun 27, 2026 12:30 UTC